Critical Challenges in ACS Management—
Resolving the Disconnect Between National ACS Guidelines and the Compelling Results of Recent Landmark Trials

Webcast CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Intended Audience:

This WebCAST is intended for emergency physicians, as well as physician specialists who manage patients in the coronary care unit, and cardiac catheterization laboratory.

Registration:

Enrollment for this WebCAST is complimentary, and clinicians are invited to attend this CME-certified symposium and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

Supported by an independent educational grant from The Medicines Company, Inc.

Accreditation Statement for Jointly-Sponsored Programs:

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Massachusetts Medical School and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 3 AMA PRA Category 1 Credit(s)^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty and Provider Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Faculty Disclosures:

Charles V. Pollack, Jr., MA, MD, FACEP, FAAEM
Consultant: TMC, Sanofi-Aventis, BMS, Schering-Plough
Speaker’s Bureau: Sanofi-Aventis, BMS, Schering-Plough

James Hoekstra, MD
Grant/Research Support: Schering Plough, Biosite
Speaker’s Bureau: Sanofi-Aventis, BMS, Schering Plough, and Medicines Company

Judd F. Hollander, MD
Grant/Research Support: Sanofi-aventis
Consultant: Sanofi-Aventis, Medicines Company, PDL, Genetech
Speaker’s Bureau: Sanofi-Aventis, Medicine Company, PDL, Genetech

Program Faculty:

Charles V. Pollack, Jr. , MA, MD, FACEP, FAAEM
(Program Chairman)
Consultant, Department of Emergency Medicine
Pennsylvania Hospital
Associate Professor of Emergency Medicine
University of Pennsylvania School of Medicine
Philadelphia, PA

James Hoekstra , MD
Professor and Chairman
Department of Emergency Medicine
Wake Forest Universty Health Sciences
Winston-Salem, NC

Judd F. Hollander , MD
Professor and Clinical Research Director
Department of Emergency Medicine
University of Pennsylvania
Philadelphia, PA

Educational Objectives:

• Emergency specialists, cardiac specialists, and other physicians will learn to risk stratify patients with ischemic coronary syndromes and identify optimal antithrombotic therapy for those undergoing PCI
• Emergency specialists, cardiac specialists, and other physicians will learn to coordinate transitioning antithrombotic care from the emergency department to the cath lab.
• Emergency specialists, cardiac specialists, and other physicians will learn evidence-based approaches to reducing bleeding complications and risk of transfusion in patients undergoing PCI
• Emergency specialists, cardiac specialists, and other physicians will learn how to select antithrombotic agents to balance reduction of ischemic complications with reduction in bleeding complications
• Emergency specialists, cardiac specialists, and other physicians will learn how landmark trials and analyses focusing on ACS can assist in guiding antithrombotic therapy.

Disclaimer:

Copyright © 2007 by Pharmatecture, LLC. All rights reserved.
Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this WebCAST reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.

Content on this WebCAST is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this WebCAST is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This WebCAST is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This WebCAST is not intended for use by the layman.

Opinions expressed herein are not necessarily those of Pharmatecture, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright (c) 2007 All rights reserved